Non-contrast-enhanced computerized tomography and analgesic-related kidney disease: Report of the National Analgesic Nephropathy Study

Journal of the American Society of Nephrology

Volumn 17, Issue 5, 2006, Pages 1472-1480

  Henrich, William L ^a,l   Clark, Richard L ^b   Kelly, Judith P ^c   Buckalew, Vardaman M ^e   Fenves, Andrew ^f   Finn, William F ^b   Shapiro, Joseph I ^g   Kimmel, Paul L ^h   Eggers, Paul ^h   Agodoa, Larry E ^h   Porter, George A ⁱ   Shapiro, Samuel ^j   Toto, Robert ^k   Anderson, Theresa ^c   Cupples, L Adrienne ^d   Kaufman, David W ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^e WAKE FOREST SCHOOL OF MEDICINE   (United States)

^f Dallas Nephrology Associates   (United States)

^g MEDICAL COLLEGE OF OHIO   (United States)

^h NATIONAL INSTITUTES OF HEALTH   (United States)

ⁱ OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^j Columbia University ^*  (United States)

^k UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^l UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; PHENACETIN;

ADULT; AGED; ANALGESIC AGENT ABUSE; ANALGESIC NEPHROPATHY; ANALYTICAL PARAMETERS; ANATOMY; ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; NATIONAL ANALGESIC NEPHROPATHY STUDY; NON CONTRAST ENHANCED COMPUTER ASSISTED TOMOGRAPHY; POPULATION RESEARCH; PRIORITY JOURNAL; SMALL INDENTED CALCIFIED KIDNEY; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; UNITED STATES;

EID: 33646384590     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005101096     Document Type: Article

References (32)

1. Dubach UC, Rosner B, Pfister E: Epidemiologic study of abuse of analgesics containing phenacetin. Renal morbidity and mortality (1968-1979). N Engl J Med 308: 357-362, 1983
2. Elseviers MM, DeBroe ME: A long-term prospective controlled study of analgesic abuse in Belgium. Kidney Int 48: 1912-1919, 1995
3. McCredie M, Steward JH, Mahony JF: Is phenacetin responsible for analgesic nephropathy in New Wales? Clin Nephrol 17: 134-140, 1982
4. Murray TG, Stolley PD, Anthony JC, Schinnar R, Hepler-Smith E, Jeffreys JL: Epidemiologic study of regular analgesic use and end-stage renal disease. Arch Intern Med 143: 1687-1693, 1983
5. Sandler DP, Weinberg CR: Analgesic use and chronic renal disease. N Engl J Med 321: 1126-1127, 1989
6. Pommer W, Glaeske G, Molzahn M: The analgesic problem in the Federal Republic of Germany: Analgesic consumption, frequency of analgesic nephropathy and regional differences. Clin Nephrol 26: 273-278, 1986
7. Morlans M, LaPorte J, Vidal X, Cabeza D, Stolley PD: End-stage renal disease and non-narcotic analgesics: A case-control study. Br J Clin Pharmacol 30: 713-717, 1990
8. Perneger TV, Whelton PK, Klag MJ: Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs. N Engl J Med 331: 1675-1679, 1994
9. Steenland NK, Thun MJ, Ferguson CW, Port FK: Occupational and other exposures associated with male end-stage renal disease: A case-control study. Am J Public Health 80: 153-159, 1990
10. Delzell E, Shapiro S: A review of epidemiologic studies of non-narcotic analgesics and chronic renal disease. Medicine 77: 102-121, 1998
11. Rexrode KM, Buring JE, Glynn RJ, Stampfer MJ, Youngman LD, Gaziano JM: Analgesic use and renal function in men. JAMA 286: 315-321, 2001
12. Elseviers MM, Bosteels V, Cambier P, De Paepe M, Godon JP, Lins R, Lornoy W, Matthys E, Moeremans C, Roose R, et al.: Diagnostic criteria of analgesic nephropathy in patients with end-stage renal failure: Results of the Belgian study. Nephrol Dial Transplant 7: 479-486, 1992
13. Elseviers MM, De Schepper A, Corthouts R, Bosmans JL, Cosyn L, Lins RL, Lornoy W, Matthys E, Roose R, Van Caesbroeck D, et al.: High diagnostic performance of CT scan for analgesic nephropathy in patients with incipient to severe renal failure. Kidney Int 48: 1316-1323, 1995
14. Buckalew VM, Schey HM: Analgesic nephropathy: A significant cause of morbidity in the United States. Am J Kidney Dis 7: 164-166, 1986
15. Bakker J, Olree M, Kaatee R, de Lange EE, Moons KG, Beutler JJ, Beek FJ: Renal volume measurements: Accuracy and repeatability of US compared with that of MRI imaging. Radiology 211: 623-628, 1999
16. Mantel N, Haenszel W: Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22: 719-748, 1959
17. Elseviers MM, Waller I, Nenoy D, Levora J, Matousovic K, Tanquerel T, Pommer W, Schwarz A, Keller E, Thieler H, et al.: Evaluation of diagnostic criteria for analgesic nephropathy in patients with end-stage renal failure: Results of the ANNE study. Analgesic Nephropathy Network of Europe. Nephrol Dial Transplant 10: 808-814, 1995
18. Landis JR, Koch GG: The measurement of observer agreement for categorical data. Biometrics 33: 159-174, 1977
19. Spuhler O, Zollinger HU: [Chronic interstitial nephritis.] Helv Med Acta 17: 564-567, 1950
20. Mihatsch MJ, Knusli C: Phenacetin abuse and malignant tumors. An autopsy study covering 25 years (1953-1977). Klin Wochenschr 60: 1339-1349, 1982
21. Bengtsson U, Angervail L, Ekman H, Lehmann L: Transitional cell tumors of the renal pelvis in analgesic abusers. Scand J Urol Nephrol 2: 145-150, 1968
22. Johansson S, Wahlqvist L: Tumors of urinary bladder and ureter associated with abuse of phenacetin-containing analgesics. Acta Pathol Microbiol Scand [A] 85: 768-774, 1977
23. Taylor JS. Carcinoma of the urinary tract and analgesic abuse. Med J Aust 1: 407-409, 1972
24. Mahony JF, Storey BG, Ibafiez RC, Stewart JH: Analgesic abuse, renal parenchymal disease and carcinoma of the kidney or ureter. Aust N Z J Med 7: 463-469, 1977
25. Steffens J, Nagel R: Tumors of the renal pelvis and ureter. Observations in 170 patients. Br J Urol 61: 277-283, 1988
26. Smith GE, Griffiths LA: Comparative metabolic studies of phenacetin and structurally related compounds in the rat. Xenobiotica 6: 217-236, 1976
27. Brodie BB, Axelrod J: The fate of acetaphenetidin (phenacetin) in man and its metabolites in biological materials. J Pharmacol Exp Ther 97: 58-67, 1949
28. Prescott LF, Steel RF, Ferrier WR: The effects of particle size on the absorption of phenacetin in man. A correlation between plasma concentration of phenacetin and effects on the central nervous system. Clin Pharmacol Ther 11: 496-500, 1970
29. Lafayette RA, Lai G: Acquired cystic kidney disease in dialysis patients. In Principles and Practice of Dialysis, 3rd ed., edited by Henrich WL, Philadelphia, Lippincott Williams & Wilkins, 2003, pp 513-524
30. McLaughlin JK, Lipworth L, Chow W-H, Blot WJ: Analgesic use and chronic renal failure: A critical review of the epidemiologic literature. Kidney Int 54: 679-686, 1998
31. Hricak H, Lieto RP: Sonographic determination of renal volume. Radiology 148: 311-812, 1983
32. Gourtsoyiannis N, Prassopoulos P, Cavouras D, Pantelidis N: The thickness of the renal parenchyma decreases with age: A CT study of 360 patients. AJR Am J Roentgenol 155: 541-544, 1990